⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8272699 | 0.93 | — | — | |
| SCHEMBL8357682 | 0.91 | PIK3CD (0.46) | — | |
| SCHEMBL16498026 | 0.84 | — | — | |
| SCHEMBL149594 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL27484353 | 0.82 | — | — | |
| Methylpyrrolidone SCHEMBL27482125 | 0.79 | BRD4 (0.65) | — | |
| Sulfur Dioxide SCHEMBL28280925 | 0.78 | PIK3CD (0.39) | — | |
| SCHEMBL12251950 | 0.76 | PIK3CD (0.59) | — | |
| SCHEMBL28083893 | 0.76 | PIK3CD (0.38) | — | |
| SCHEMBL24245134 | 0.75 | PIK3CD (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092069-A1 | SUBSTITUTED INDAZOLES AS IRAK4 INHIBITORS | ASTRAZENECA AB (SE) | 2026-04-02 | — | — | US | claimed |
| EP-3205010-B1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | C MOTIVE TECH INC (US) | 2026-03-11 | — | — | EP | claimed |
| US-20240182479-A1 | SUBSTITUTED INDAZOLES AS IRAK4 INHIBITORS | ASTRAZENECA AB (SE) | 2024-06-06 | — | — | US | claimed |
| EP-4259632-A1 | N-(IMIDAZO[1,2-B]PYRIDAZIN-3-YL)-1-CYCLOHEXYL-2H-INDAZOLE-5-CARBOXAMIDE AND N-(PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-1-CYCLOHEXYL-2H-INDAZOLE-5-CARBOXAMIDE DERIVATIVES AS IRAK4 INHIBITORS FOR THE TREATMENT OF ASTHMA | Astrazeneca AB (SE) | 2023-10-18 | — | — | EP | claimed |
| CN-116583285-A | N- (imidazo [1,2-b ] pyridazin-3-yl) -1-cyclohexyl-2H-indazole-5-carboxamide and N- (pyrazolo [1,5-a ] pyrimidin-3-yl) -1-cyclohexyl-2H-indazole-5-carboxamide derivatives as IRAK4 inhibitors for the treatment of asthma | 阿斯利康(瑞典)有限公司 | 2023-08-11 | — | — | CN | claimed |
| US-20230223869-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | C-Motive Technologies, Inc. (US) | 2023-07-13 | — | — | US | claimed |
| US-11601069-B2 | Electrostatic machines that include a malonate in a dielectric fluid | C-Motive Technologies, Inc. (US) | 2023-03-07 | — | — | US | claimed |
| US-20220185817-A1 | IRAK4 INHIBITORS | ASTRAZENECA AB (SE) | 2022-06-16 | — | — | US | claimed |
| WO-2022122876-A1 | N-(IMIDAZO[1,2-B]PYRIDAZIN-3-YL)-1-CYCLOHEXYL-2H-INDAZOLE-5-CARBOXAMIDE AND N-(PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-1-CYCLOHEXYL-2H-INDAZOLE-5-CARBOXAMIDE DERIVATIVES AS IRAK4 INHIBITORS FOR THE TREATMENT OF ASTHMA | ASTRAZENECA AB (SE) | 2022-06-16 | — | — | WO | claimed |
| US-20210391809-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | NATIONAL SCIENCE FOUNDATION | 2021-12-16 | — | — | US | claimed |
| US-20190296659-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | C-MOTIVE TECHNOLOGIES INC. (US) | 2019-09-26 | — | — | US | claimed |
| US-9866148-B2 | Electrostatic machine system and method of operation | C-MOTIVE TECHNOLOGIES INC. (US) | 2018-01-09 | — | — | US | claimed |
| EP-3205010-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | C-Motive Technologies Inc. (US) | 2017-08-16 | — | — | EP | claimed |
| US-20160099663-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | NATIONAL SCIENCE FOUNDATION | 2016-04-07 | — | — | US | claimed |
| US-7186844-B2 | Method for producing cyclic carbamate ester | MITSUBISHI GAS CHEMICAL CO., INC. (JP) | 2007-03-06 | — | — | US | claimed |
| US-20050154200-A1 | Method for producing cyclic carbamate ester | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-07-14 | — | — | US | claimed |
| US-6657015-B1 | Method for the secondary cross-linking of hydrogels with 2-oxotetrahydro-1,3-oxazines | BASF AKTIENGESELLSCHAFT (DE) | 2003-12-02 | — | — | US | claimed |
| EP-0632022-B1 | Process for the preparation of amino-substituted thioethers | BAYER AG (DE) | 1996-12-27 | — | — | EP | claimed |
| US-5410081-A | Process for the preparation of amino-substituted thioethers | BAYER AKTIENGESELLSCHAFT (DE) | 1995-04-25 | — | — | US | claimed |
| EP-0632022-A2 | Process for the preparation of amino-substituted thioethers | BAYER AG (DE) | 1995-01-04 | — | — | EP | claimed |